Short multi-repeat rna targeting gene silencing
US-2024182899-A1 · Jun 6, 2024 · US
US10351610B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10351610-B2 |
| Application number | US-201313757674-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 1, 2013 |
| Priority date | Feb 2, 2012 |
| Publication date | Jul 16, 2019 |
| Grant date | Jul 16, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This disclosure concerns compositions and methods for increasing the expression of a polynucleotide of interest. Some embodiments concern novel transactivation polypeptides and variants thereof that have been identified in plants, and methods of using the same. Particular embodiments concern the use of at least one DNA-binding polypeptide in a fusion protein to target at least one transactivation polypeptide or variant thereof to a specific binding site on a nucleic acid comprising the polynucleotide of interest, such that its expression may be increased.
Opening claim text (preview).
What may be claimed is: 1. A synthetic transcriptional activator fusion protein comprising: a single DNA-binding peptide; and a heterologous transactivation domain comprising the interaction motif peptide of SEQ ID NO:22. 2. The synthetic transcriptional activator fusion protein of claim 1 , wherein the DNA-binding peptide is selected from the group consisting of a zinc finger DNA-binding domain; a consensus binding sequence from a AVRBS3-inducible gene or synthetic binding sequence engineered therefrom; TAL; LexA; a Tet repressor; LacR; and a steroid hormone receptor. 3. The synthetic transcriptional activator fusion protein of claim 2 , wherein the DNA-binding peptide is a zinc finger DNA-binding domain. 4. The synthetic transcriptional activator fusion protein of claim 1 , wherein the transactivation domain comprises an amino acid sequence that is at least 80% identical to SEQ ID NO:107 or SEQ ID NO:108. 5. The synthetic transcriptional activator fusion protein of claim 1 , wherein the transactivation domain comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:107 or SEQ ID NO:108. 6. The synthetic transcriptional activator fusion protein of claim 1 , wherein the transactivation domain comprises SEQ ID NO:107 or SEQ ID NO:108. 7. A nucleic acid molecule comprising a polynucleotide encoding the synthetic transcriptional activator fusion protein of claim 1 , the polynucleotide comprising: a first nucleotide sequence encoding the DNA-binding peptide; and a second nucleotide sequence encoding the heterologous transactivation domain, wherein the first and second nucleotide sequences are expressed from the nucleic acid molecule in frame and in a single transcript. 8. The nucleic acid molecule of claim 7 , wherein the first and second nucleotide sequences are separated by a third nucleotide sequence in the polynucleotide. 9. The nucleic acid molecule of claim 7 , wherein the polynucleotide is operably linked to a gene regulatory element. 10. A vector comprising the nucleic acid molecule of claim 9 . 11. The nucleic acid molecule of claim 9 , wherein the gene regulatory element is a promoter that is functional in a plant cell. 12. A host cell comprising the nucleic acid molecule of claim 9 . 13. The host cell of claim 12 , wherein the host cell is a plant cell or a yeast cell. 14. A plant cell comprising the nucleic acid molecule of claim 11 . 15. The plant cell of claim 14 , wherein the polynucleotide and gene regulatory element are integrated into the genome of the cell. 16. A transgenic plant material comprising the nucleic acid molecule of claim 11 . 17. The transgenic plant material of claim 16 , wherein the plant material is a plant cell, plant cell culture, plant tissue, plant tissue culture, plant part, plant commodity product, or whole plant. 18. The transgenic plant material of claim 17 , wherein the plant material is a plant cell, plant cell culture, plant tissue, plant tissue culture, plant part, or whole plant. 19. A method for increasing the expression of a polynucleotide of interest in a host cell, the method comprising: introducing the nucleic acid molecule of claim 9 into a host cell comprising the polynucleotide of interest, wherein the polynucleotide of interest is operably linked to a second polynucleotide that binds specifically to the DNA-binding peptide, thereby increasing the expression of the polynucleotide of interest in the host cell. 20. The method according to claim 19 , wherein the host cell is a plant cell. 21. The method according to claim 20 , wherein introducing the nucleic acid molecule into the host cell comprises crossing a plant comprising the polynucleotide encoding the synthetic transcriptional activator fusion protein with a plant comprising the host cell. 22. The method according to claim 19 , wherein the introducing into the host cell a nucleic acid molecule comprises transforming said host cell with the nucleic acid molecule encoding the synthetic transcriptional activator protein. 23. The nucleic acid molecule of claim 7 , wherein the synthetic transcriptional activator fusion protein further comprising a promoter and a 3′UTR.
Methods for controlling, regulating or enhancing expression of transgenes in plant cells · CPC title
Phosphinothricin acetyltransferase (2.3.1.183) · CPC title
Gene switch · CPC title
containing a Zn-finger domain for DNA binding · CPC title
containing domain for transcriptional activaation, e.g. VP16 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.